Hancom Lifecare Inc. (KRX:372910)
South Korea
· Delayed Price · Currency is KRW 3,420.00
+115.00 (3.48%)
At close: Mar 24, 2025, 3:30 PM KST
Hancom Lifecare Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Operating Revenue | 104,776 | 112,780 | 100,120 | 121,140 | 151,842 | Upgrade
|
| Other Revenue | - | - | -0 | - | - | Upgrade
|
| Revenue | 104,776 | 112,780 | 100,120 | 121,140 | 151,842 | Upgrade
|
| Revenue Growth (YoY) | -7.10% | 12.64% | -17.35% | -20.22% | 128.04% | Upgrade
|
| Cost of Revenue | 75,875 | 89,332 | 80,478 | 93,418 | 94,040 | Upgrade
|
| Gross Profit | 28,902 | 23,448 | 19,642 | 27,722 | 57,802 | Upgrade
|
| Selling, General & Admin | 19,481 | 19,403 | 18,634 | 20,480 | 17,697 | Upgrade
|
| Research & Development | 234.02 | 440.61 | 798.4 | 530.5 | 62.6 | Upgrade
|
| Other Operating Expenses | 354.32 | 364.49 | 412.76 | 239.3 | 331.08 | Upgrade
|
| Operating Expenses | 21,485 | 21,616 | 21,065 | 22,942 | 19,088 | Upgrade
|
| Operating Income | 7,416 | 1,832 | -1,423 | 4,781 | 38,714 | Upgrade
|
| Interest Expense | -31.45 | -182.08 | -131.58 | -468.74 | -6,893 | Upgrade
|
| Interest & Investment Income | 478.1 | 650.33 | 736.56 | 104.71 | 96.25 | Upgrade
|
| Currency Exchange Gain (Loss) | 1,207 | 256.32 | -142.03 | 788.62 | -259.37 | Upgrade
|
| Other Non Operating Income (Expenses) | -70.69 | -382.05 | -914.27 | -904.66 | 162.02 | Upgrade
|
| EBT Excluding Unusual Items | 9,000 | 2,175 | -1,874 | 4,301 | 31,821 | Upgrade
|
| Gain (Loss) on Sale of Investments | 8.87 | 5.33 | 23,920 | -39.44 | 563.03 | Upgrade
|
| Gain (Loss) on Sale of Assets | 73.98 | 157.83 | -18.34 | 1,333 | -49.09 | Upgrade
|
| Asset Writedown | - | -713.2 | -8,791 | - | - | Upgrade
|
| Pretax Income | 9,082 | 1,625 | 13,236 | 5,594 | 32,335 | Upgrade
|
| Income Tax Expense | 1,747 | 753.4 | 3,966 | 759.05 | 4,645 | Upgrade
|
| Earnings From Continuing Operations | 7,336 | 871.12 | 9,269 | 4,835 | 27,690 | Upgrade
|
| Minority Interest in Earnings | 38.76 | -46.41 | -65.47 | - | - | Upgrade
|
| Net Income | 7,375 | 824.71 | 9,204 | 4,835 | 27,690 | Upgrade
|
| Net Income to Common | 7,375 | 824.71 | 9,204 | 4,835 | 27,690 | Upgrade
|
| Net Income Growth | 794.20% | -91.04% | 90.36% | -82.54% | - | Upgrade
|
| Shares Outstanding (Basic) | 28 | 28 | 28 | 25 | 14 | Upgrade
|
| Shares Outstanding (Diluted) | 28 | 28 | 28 | 25 | 25 | Upgrade
|
| Shares Change (YoY) | - | - | 12.31% | -1.17% | 12366.52% | Upgrade
|
| EPS (Basic) | 266.48 | 29.80 | 332.58 | 196.22 | 1967.04 | Upgrade
|
| EPS (Diluted) | 266.00 | 29.80 | 332.58 | 196.00 | 1301.58 | Upgrade
|
| EPS Growth | 792.60% | -91.04% | 69.68% | -84.94% | - | Upgrade
|
| Free Cash Flow | 18,164 | -13,550 | -681.63 | 18,826 | -9,958 | Upgrade
|
| Free Cash Flow Per Share | 656.33 | -489.62 | -24.63 | 764.02 | -399.40 | Upgrade
|
| Gross Margin | 27.58% | 20.79% | 19.62% | 22.88% | 38.07% | Upgrade
|
| Operating Margin | 7.08% | 1.62% | -1.42% | 3.95% | 25.50% | Upgrade
|
| Profit Margin | 7.04% | 0.73% | 9.19% | 3.99% | 18.24% | Upgrade
|
| Free Cash Flow Margin | 17.34% | -12.01% | -0.68% | 15.54% | -6.56% | Upgrade
|
| EBITDA | 13,020 | 8,916 | 5,800 | 12,611 | 45,251 | Upgrade
|
| EBITDA Margin | 12.43% | 7.91% | 5.79% | 10.41% | 29.80% | Upgrade
|
| D&A For EBITDA | 5,604 | 7,084 | 7,223 | 7,831 | 6,536 | Upgrade
|
| EBIT | 7,416 | 1,832 | -1,423 | 4,781 | 38,714 | Upgrade
|
| EBIT Margin | 7.08% | 1.62% | -1.42% | 3.95% | 25.50% | Upgrade
|
| Effective Tax Rate | 19.23% | 46.38% | 29.97% | 13.57% | 14.37% | Upgrade
|
| Advertising Expenses | 706.96 | 764.06 | 1,094 | 865.79 | 777.2 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.